Generic Drugs

India pledges $15-mn at virtual global vaccine summit; funds to be used for immunisation programmes across the world

Prime Minister Narendra Modi on Thursday pledged $15-million as India's contribution to the vaccines alliance GAVI at the Global Vaccine Summit hosted by the UK

Budget 2020: Policy reforms, additional outlay only way to boost life science, healthcare and pharmaceutical industry

Given the ambition of the government to make India a $5 trillion economy in the next five years, pharmaceutical and life science could be the ‘Target sector’ in Budget 2020 for reforms,

Pfizer in talks to merge off-patent drugs business with Mylan in a stock deal; plans to form global generic drug giant: Report

Pfizer Inc plans to combine its off-patent business, which includes Lipitor cholesterol pills and male impotence drug Viagra, with Mylan NV

US-China trade war: Beijing opens to Indian pharma companies as it looks for new commercial partners

Swift regulatory approvals in China would allow Indian companies to boost revenue at a time when pricing scrutiny and regulatory troubles have hurt US sales

Narendra Modi in London: PM's remarks on doctors rile medicos, but studies confirm high costs ail India's healthcare

Narendra Modi's remarks in London on doctors have evoked much outrage. However, several studies indicate that this anger is not justified.

Uttar Pradesh to become second state after Karnataka to have state-specific health policy

UP government is in the process of finalising the state's first-ever state health policy and it is likely to be notified in the next three months.

New pharma policy will make drugs cheaper but accessibility remains a concern

According to the newly proposed draft national pharmaceutical policy, the government plans to cap trade margins to make drugs cheaper, replace brand names with names of salts or generic drugs, clamp down on unfair marketing practices and give a boost to local manufacturing to reduce dependence on imports.

Generic versions for Hepatitis C treatment cost-effective in terms of life expectancy: Study

About 71 million people are estimated to be affected with chronic Hepatitis C infection globally and of them six to 11 million are estimated to be in India

Why branded drugs cost way more than their generic counterparts

The medicines available in the market then were all branded and each manufacturer of medicine had their own way to prepare a certain drug.

Dr Reddy's shares hit near three-year low, drops 4% as Duvvada unit receives 13 observations from US FDA

The Duvvuda unit makes cytotoxic and hormonal injectables. It is an important unit for Dr Reddy’s